Yttrium oxide nanoparticles induce potent selective cytotoxicity in HeLa cervical cancer cells through ROS-mediated genomic instability and mitochondrial apoptosis.
Nanoparticles show promise in lab tests of cervical cancer cells, advancing early research toward potential future treatments.
In vitro study demonstrating yttrium oxide nanoparticle toxicity in cervical cancer cells via oxidative stress pathways. Early-stage preclinical finding with no clinical relevance at this stage.
What the study was
- Study design
- In vitro cytotoxicity study
- Category
- Drug Development
- Maturity
- Exploratory
- Journal
- Scientific reports
Why it surfaced
In vitro nanoparticle cytotoxicity; minimal watchlist relevance, excluded from pipeline.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.